{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-000481","form_type":"8-K","ticker":"CCEL","cik":"0000862692","company_name":"CRYO CELL INTERNATIONAL INC","filed_at":"2022-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.076841+00:00","generated_at":"2026-06-27T16:04:55.324482+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cryo-Cell receives Nasdaq notice for audit committee non-compliance; cure period until Sept 2022","bullets":["Nasdaq notified that audit committee has only 2 independent members, needs 3 per Rule 5605.","Cure period: earlier of next annual meeting or September 20, 2022 (or March 21, 2022 if meeting before that).","Company must submit documentation evidencing compliance by the cure deadline.","Cryo-Cell states it is working diligently to regain compliance within the cure period."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-000481","json":"https://secwatch.observer/filing/0000950170-22-000481.json","markdown":"https://secwatch.observer/filing/0000950170-22-000481.md","text":"https://secwatch.observer/filing/0000950170-22-000481.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/862692/000095017022000481/0000950170-22-000481-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/862692/000095017022000481/ccel-20220119.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T16:04:55.324482+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}